0001127602-22-005441.txt : 20220217 0001127602-22-005441.hdr.sgml : 20220217 20220217112257 ACCESSION NUMBER: 0001127602-22-005441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WELTZIEN LOURDES CENTRAL INDEX KEY: 0001201184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 22646337 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-15 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001201184 WELTZIEN LOURDES 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 EVP, Life Science Common Stock 2022-02-15 4 M 0 12500 14.65 A 95548 D Common Stock 2022-02-15 4 M 0 7500 14.30 A 103048 D Common Stock 2022-02-15 4 S 0 20000 25.5956 D 83048 D Stock Options (Right to Buy) 14.65 2022-02-15 4 M 0 12500 0 D 2027-11-08 Common Stock 12500 0 D Stock Options (Right to Buy) 14.30 2022-02-15 4 M 0 7500 0 D 2028-04-24 Common Stock 7500 2500 D The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $25.29 to $26.07. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. These non-qualified options were awarded under the 2012 Stock Incentive Plan and cliff vested in full on November 15, 2021. These options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on April 24, 2022. /s/ F. Mark Reuter as Attorney-in-Fact for Lourdes G. Weltzien 2022-02-17